Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Forkhead box protein O1 (FOXO1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the FOXO1 transcript that governs the stability and translation efficiency of the FOXO1 protein (UniProt P12733). FOXO1 is a key transcription factor that integrates signals from the insulin and growth factor pathways to regulate metabolism, cellular stress responses, and apoptosis (PubMed: 25605729). The 3'-UTR contains multiple conserved binding sites for microRNAs, such as miR-27a, miR-96, and miR-182, which act as post-transcriptional rheostats to fine-tune FOXO1 expression (PubMed: 21832034, PubMed: 19648124). In diseases like type 2 diabetes and various cancers, the dysregulation of these miRNA-mRNA interactions leads to aberrant FOXO1 levels, contributing to disease progression. For example, the overexpression of miRNAs targeting the FOXO1 3'-UTR can downregulate this tumor suppressor, promoting cell proliferation and survival in malignancies like prostate and breast cancer. Consequently, the FOXO1 mRNA 3'-UTR is an emerging therapeutic target for antisense oligonucleotides (ASOs) and miRNA-based therapies designed to restore or inhibit FOXO1 expression. Targeting this region offers a strategic advantage by allowing for the modulation of FOXO1 activity indirectly, potentially overcoming the pharmacological challenges associated with directly targeting transcription factors with small molecules.
Modulation of FOXO1 protein levels via RNA interference (RNAi), steric hindrance of microRNA binding sites, or targeted mRNA degradation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein O1 (FOXO1) mRNA 3'-untranslated region (3'-UTR) (FOXO1 mRNA 3'-UTR).